Navigation Links
University at Buffalo launches clinical trial of new multiple sclerosis treatment
Date:6/30/2010

ences, with co-principal investigators Elad Levy, MD, associate professor, and L.N. Hopkins, MD, professor and chair of the UB Department of Neurosurgery .

Additional independent researchers from University at Buffalo will participate in the evaluation and follow-up of study patients. An independent Data Safety Monitoring Board (DSMB) will ensure the safety and effectiveness of the study on an ongoing basis.

In the first phase of the study, ten MS patients from the United States and Canada who exhibit venous insufficiency will undergo minimally invasive venous angioplasties to determine if the procedure can be performed safely. The procedures began June 29 and will continue today (June 30), performed by Siddiqui and Levy at Kaleida Health's Millard Fillmore Gates Hospital in Buffalo, New York.

In its second phase, the study will randomize 20 MS patients who will undergo either venous angioplasty or a "sham angioplasty" (i.e. a catheter will be inserted but there will be no inflation of the balloon). The treatment will be blinded in such a way that neither the patient undergoing the procedure nor the clinicians evaluating the patient will be aware which procedure was performed.

If results suggest an appropriate safety profile and preliminary effectiveness, researchers will approach the University at Buffalo IRB for an extension of the protocol to study a larger number of patients in order to convincingly prove or disprove a causal relationship between CCSVI and MS.

Multiple sclerosis is estimated to affect more than 400,000 people in the United States and more than two million people worldwide. It is typically a disease of young adults characterized by either a relapsing or progressive decline in neurologic function resulting in significant disability. It is an inflammatory neurological disease widely considered to be autoimmune in nature, though its exact origins remain elusive.

If angioplasty is proven effective at im
'/>"/>

Contact: Paul Dressel
pdressel@ubns.com
716-887-5200 x2150
University at Buffalo
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Bridgepoint Educations University of the Rockies Introduces New Master of Arts Specialization in Career Management and Counseling
2. University of Maryland chemist receives Astellas Award for blindness prevention research
3. Morehead Presents Webinar on “Building Employee Engagement in a University Healthcare Environment”
4. Oakland University William Beaumont School of Medicine Reaches Development Milestone
5. Women should be allowed to eat, drink during labor: Queens University researcher
6. University of Alberta researchers develop drug interface to save lives
7. University of Utah Announces New Studies on the Benefits of Treadmill Desks
8. St. Jude and Washington University team to unravel genetic basis of childhood cancers
9. Childhood Apraxia of Speech Association of North America Awards Treatment Research Grant to University of New Mexico/PROMPT Institute
10. Disease of Poverty: University of South Carolina Releases Journal on Cervical Cancer, Health Disparities
11. University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Womens Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... 2014) The American Gastroenterological Association (AGA) Research ... Research Scholars. The AGA Research Scholar Awards program, ... independent and productive research careers in digestive diseases. ... an additional year allowing for three consecutive years ... junior faculty who are paving the way for ...
(Date:4/23/2014)... a country as wealthy as the United States, it may ... not have access to adequate food due to lack of ... , Recent research at the University of Illinois using data ... that the seniors who are dealing with hunger are also ... 8.35 percent of Americans over age 60 faced the threat ...
(Date:4/23/2014)... and physicians concerned about an increase in adolescents, marijuana ... a sigh of relief. According to a new study ... of data from states with and without medical marijuana ... use among adolescents. The study is published online in ... Health . , "Any time a state considers ...
(Date:4/23/2014)... the depletion of self-control, according to research published in ... for Psychological Science. , Self-control can be difficult ... on a boring textbook are hard things to do. ... Exerting self-control for a long period seems to "deplete" ... , "It is as if self-control is a limited ...
(Date:4/22/2014)... high school sport in the United States with 1 ... in the Center for Injury Research and Policy at ... describe the occurrence and distribution patterns of basketball-related injuries ... training setting among adolescents and teens. , The study, ... , examined data relating to adolescents 13-19 years of ...
Breaking Medicine News(10 mins):Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:More Americans in their golden years are going hungry 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2Health News:ADHD drug may help preserve our self-control resources 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 3
... , ... Health GPS uses the latest technology to help women locate the closest medical ... was developed by the Breast Health & Healing Foundation, (BHH&F) www.breasthealthandhealing.com , a ... , ...
... (TSX Venture: DIV, OTC Bulletin Board: DVNTF) is increasing its focus on secure mobile healthcare, the company announced today at CTIA Wireless 2010. , ... , ... ... ...
... to better predict the effects of strokes and other ... for study of brain organization, neurologists at Washington University ... The technique, known as resting-state functional connectivity (FC), reveals ... of the brain collaborate. Previous studies have shown that ...
... ,CAMDEN Americans consume innumerable amounts of medicine, but only ... marks the 50th anniversary of oral contraception, an innovative collaboration ... the development of the 20th century. As ... comprehensive biography on Rock has its origins at Rutgers UniversityCamden. ...
... ago, findings suggest , TUESDAY, March 23 (HealthDay ... are the earliest direct evidence that our tree-dwelling ancestors ... fossil footprints preserved in volcanic ash were discovered in ... have debated whether the tracks indicate a modern human-like ...
... ... the survivors of the earthquake in Haiti. The Grand Canyon University community has donated more ... struck on January 12, 2010. , ... Phoenix, AZ (PRWEB) March 23, 2010 -- Grand Canyon University,s Compassion and ...
Cached Medicine News:Health News:IPhone App is New Tool in the Fight Against Breast Cancer 2Health News:Diversinet Expands Mobile Healthcare Focus 2Health News:Diversinet Expands Mobile Healthcare Focus 3Health News:Diversinet Expands Mobile Healthcare Focus 4Health News:Diversinet Expands Mobile Healthcare Focus 5Health News:Diversinet Expands Mobile Healthcare Focus 6Health News:Diversinet Expands Mobile Healthcare Focus 7Health News:Diversinet Expands Mobile Healthcare Focus 8Health News:Diversinet Expands Mobile Healthcare Focus 9Health News:Diversinet Expands Mobile Healthcare Focus 10Health News:Scans of brain networks may help predict injury's effects 2Health News:Rutgers historian puts 50th anniversary of the pill into cultural medicine cabinet 2Health News:Rutgers historian puts 50th anniversary of the pill into cultural medicine cabinet 3Health News:Grand Canyon University (GCU) Creates Special Relief Fund and Raises Money for Haiti Earthquake Survivors 2
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ( ... "Dental Consumables Market - Global Industry Analysis, Size, Share, ... to their offering. (Logo: ... which are used on patients in order to treat ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)... an unprecedented effort to curb the spread of "superbugs" such as ... an advanced and portable UV germicidal lamp manufactured by MRSA-UV is ... In order to prevent EMS paramedics and transport patients ... Palm Beach Fire Rescue is the first in the ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2
... Remission / Unconfirmed Complete Remission Rate 3.5 Fold Higher ... Compared to Standard ... and MTA: CTIC) announced today that it achieved the primary,efficacy ... for patients with advanced, relapsed aggressive non-Hodgkin,s,lymphoma (NHL) based on ...
... PRINCETON, N.J., Nov. 10 Pharmasset, Inc.,(Nasdaq: VRUS ... ITMN ) today,announced that the first patients have been ... with the hepatitis C virus (HCV).,The trial (run in ... to,investigate the combination of two oral antiviral molecules in ...
Cached Medicine Technology:Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 2Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 3Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 4Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 2Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 3Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 4Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 5
... Gore's EXCLUDER AAA Endoprosthesis is an ... invasive treatment option for patients with abdominal ... a durable ePTFE bifurcated graft with an ... both device flexibility and material durability. The ...
... remove a cast from an arm or leg ... are cut or burned by the cast saw ... to remove any cast with confidence. This innovative, ... and burns from the cast saw and can ...
... choice plays an important part in ... particularly where reduced capsule formation, inflammation ... considerations. GORE-TEX Suture, a nonabsorbable, ePTFE ... characteristics sought by a variety of ...
... Patch utilizes advanced fluoropolymer technology, ... penetrating suture and decrease suture ... as 88 percent. This improvement, ... multi-directional strength and low thrombogenicity, ...
Medicine Products: